Third-party testing and purity analysis This is where claims meet reality
Driven by SELECT cardiovascular outcomes trial label inclusion and ongoing Phase 3 programs in HFpEF and cardiac rehabilitation settings demonstrating a 20% reduction in MACE events
During maintenance (12+ months), refine your approach based on what you have learned about your individual response
Expecting the rapid losses seen in the first 12-16 weeks to continue indefinitely sets unrealistic expectations
Semaglutide is a medication that helps to lower blood sugar, which can lead to weight loss, explains Shiara Ortiz-Pujols, M.D., an obesity medicine physician at Northwell Staten Island University Hospital
Thanks to the latest tracking toolsfrom next-gen continuous glucose monitors to emerging breath sensorsyou can now see how stress, sleep, workouts, and meals affect those fuel shifts in real time instead of guessing